Insurers are evaluating the costs and benefits of generic testing to determine their level of commitment to the emerging medical discipline.
Depressive disorders stand out as a major occupational health issue, and employers are feeling the burden in reduced productivity and higher healthcare costs for their work forces.
WellPoint supports putting gold-standard generics in most drug classes on the first tier.
Through its research correlating copayments with utilization, Express Scripts, a pharmacy benefits manager (PBM) in St. Louis, found that a three-tier structure can control prescription drug costs without causing any unintended consequences, such as visits to the emergency room or hospitalizations.
Workers’ comp pays 74% more than group health for the same drugs, due to lack of control over AWP and limited purchasing power.
Vouchers, bargains and other marketing teasers inspire members to try less-expensive generics
Educational pregnancy programs targeting minority members and those with risk factors help deliver optimal outcomes
FMCP model urges plans to think outside the cost silo when making formulary decisions
With new coalitions and programs similar
to commercial plans, states are keeping
a handle on Medicaid drug spending